S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

IGC Pharma (IGC) SEC Filings & 10K Form

$0.48
-0.11 (-18.77%)
(As of 04/18/2024 ET)

Recent IGC Pharma SEC Filings

DateFilerForm TypeView
04/05/2024
10:33 AM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
8:27 PM
GRIMALDI CLAUDIA (Reporting)
IGC Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
8:05 PM
IGC Pharma (Issuer)
Moran James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
8:09 PM
IGC Pharma (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
7:32 PM
IGC Pharma (Subject)
MUKUNDA RAM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
4:34 PM
IGC Pharma (Issuer)
LIERMAN TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
8:00 AM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
4:09 PM
IGC Pharma (Issuer)
LIERMAN TERRY L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2024
11:15 PM
IGC Pharma (Filer)
Form EFFECT
11/09/2023
4:15 PM
IGC Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2023
4:21 PM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
3:38 PM
IGC Pharma (Filer)
Form 424B5
10/05/2023
11:15 PM
IGC Pharma (Filer)
Form EFFECT
09/29/2023
4:23 PM
IGC Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/21/2023
11:44 AM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:15 PM
IGC Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/07/2023
10:41 AM
IGC Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
8:25 PM
GRIMALDI CLAUDIA (Reporting)
IGC Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
12:46 PM
IGC Pharma (Issuer)
Moran James P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
7:20 PM
IGC Pharma (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
5:10 PM
IGC Pharma (Issuer)
MUKUNDA RAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSEAMERICAN:IGC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners